Market Update: Crinetics Pharmaceuticals Surges 100% as Rivian (RIVN) and Micron (MU) Stocks Tumble

Key Highlights

Table of Contents

Crinetics Pharmaceuticals shares surged 100% following Vertex Pharmaceuticals’ $10 billion cash acquisition announcement
Rivian Automotive declined 9% after revealing plans to sell 75 million shares to pay down federal debt
Micron Technology slipped 5% amid concerns over potential memory chip oversupply from increased Samsung and SK Hynix capital expenditure
Fiserv climbed as much as 8% following reports of potential STAR Network sale negotiations with leading banks
Semiconductor and AI-related equities experienced broad declines, with Intel falling 4.4% and Samsung dropping nearly 7%

Semiconductor and artificial intelligence stocks experienced significant premarket declines on Tuesday, July 7, signaling a swift reversal of Monday’s positive momentum.

The downturn began overnight with Samsung Electronics. Despite projecting a substantial profit increase, the South Korean technology giant saw its shares plunge nearly 7% as investors responded negatively to the earnings outlook.

This weakness quickly cascaded into American markets. Intel Corporation declined 4.4% while Micron Technology retreated 5.8% during premarket hours.

Intel Corp., INTC

Additional declines were observed in Advanced Micro Devices, Corning, Marvell Technology, and Super Micro Computer. Each of these companies maintains significant exposure to the artificial intelligence market.

Nasdaq futures declined while Dow futures demonstrated greater resilience. Market participants appeared to be reassessing AI stock valuations in anticipation of key economic releases scheduled for later this week.

Crinetics Pharmaceuticals Soars on Vertex Acquisition

Crinetics Pharmaceuticals emerged as the session’s most dramatic winner. The stock rocketed 100% higher, trading at $83.66 during premarket activity.

Vertex Pharmaceuticals announced an agreement to acquire Crinetics at $85 per share in an entirely cash transaction. The deal values the company’s equity at approximately $10 billion.

Transaction completion is anticipated in the third quarter of 2026. Vertex highlighted that the acquisition would provide immediate revenue through Palsonify’s commercial launch, a therapy designed for acromegaly treatment.

Vertex executives also emphasized pipeline candidate atumelnant as representing a potential multi-billion-dollar revenue opportunity. The companies project that their combined product portfolio will deliver over $5 billion in peak yearly sales.

Fiserv shares also advanced, climbing between 6% and 8%. The Wall Street Journal disclosed that JPMorgan Chase, Bank of America, Wells Fargo, and PNC Financial Services have engaged in discussions to acquire Fiserv’s STAR Network payment processing division.

Rivian Slides on Equity Offering, Micron Pressured by Oversupply Concerns

Rivian Automotive ranked among the session’s weakest performers. The electric vehicle manufacturer’s shares dropped approximately 9% following disclosure of a 75 million Class A share offering.

The capital raised will support general corporate needs, with a portion designated to retire a $4.5 billion government-backed loan from the U.S. Department of Energy.

Despite the share dilution, Rivian provided second-quarter revenue projections exceeding analyst expectations. Management forecast revenue between $1.55 billion and $1.65 billion, surpassing the $1.44 billion Wall Street consensus estimate.

Micron Technology declined roughly 5%. Market concerns centered on aggressive capital deployment by Samsung and SK Hynix, which analysts fear could create memory chip oversupply conditions and depress pricing.

SpaceX edged down 1.3% in premarket trading. The aerospace company was scheduled to enter the Nasdaq 100 index before Tuesday’s opening bell.

Stock index futures presented a mixed picture. The day’s trading dynamics illustrated a market balancing enthusiasm over a major biotechnology acquisition against headwinds facing semiconductor and electric vehicle sectors.

✨ Limited Time Offer